Dabur India Share Price Target 2026 Analyst Forecast Bull and Bear Case
- June 18, 2026
- Posted by: Kunal Singla
- Category: News
The Dabur India share price target 2026 is Rs 525, implying approximately 20 percent upside from the current market price of Rs 435.45 (NSE: DABUR). With Q4 FY26 results released in 2026 and FMCG Healthcare and Ayurveda tailwinds in focus, the Rs 525 price objective is supported by the FY27 earnings recovery thesis.
Dabur India (NSE: DABUR) is a FMCG Healthcare and Ayurveda company trading at Rs 435.45 with a market capitalisation of Rs 77,017 crore. Analysts have set the Dabur India share price target at Rs 525 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast including sector tailwinds, key risks, and bull and bear scenarios.
Click Here – Get Free Investment Predictions
Dabur India Share Price Target 2026: Key Takeaways
- Dabur India share price target 2026: Rs 525 (20% upside from CMP Rs 435.45)
- Bull case: Rs 630 | Bear case: Rs 350
- Ticker: DABUR | Sector: FMCG Healthcare and Ayurveda | MCap: Rs 77,017 crore
- 52W range: Rs 302 to Rs 714 | PE: 40x
- Key catalyst: Q4 FY26 results and FY27 earnings confirmation in 2026
- Key risk: FY27 earnings miss or FII outflows from Indian equities
Dabur India Company Overview
Dabur India (NSE: DABUR) is a New Delhi-based India’s largest Ayurvedic and natural healthcare FMCG company with brands including Dabur Chyawanprash, Dabur Honey, Real juices, Vatika, OralB, and Hajmola, with FY26 revenue of Rs 13,000 crore and international operations in 120-plus countries. At CMP Rs 435.45 against a 52 week range of Rs 302 to Rs 714, the stock trades at a discount to its 52 week high. Market capitalisation is Rs 77,017 crore with trailing PE of 40x. Compared to peers in FMCG like Himalaya Drug and Patanjali, Dabur India is positioned as a potential re-rating candidate toward the Rs 525 price objective on FY27 earnings delivery.
| Parameter | Value |
|---|---|
| NSE Ticker | DABUR |
| Sector | FMCG Healthcare and Ayurveda |
| CMP (2026) | Rs 435.45 |
| 52 Week High | Rs 714 |
| 52 Week Low | Rs 302 |
| Market Cap | Rs 77,017 crore |
| Trailing PE | 40x |
| 12-Month Analyst Target | Rs 525 |
| Bull Case Target | Rs 630 |
| Bear Case Target | Rs 350 |
3 Stocks Building Serious Momentum Right Now
When Univest analysts identify high-conviction opportunities, investors pay attention.
Our research team has shortlisted the Top Stocks to Buy based on market momentum, sector trends & growth potential for 2026.
- Discover stocks investors are actively accumulating
- High-conviction opportunities backed by research
- Designed for the next phase of market growth
Unlock the latest Top Stock Picks now on Univest
Why Is the Dabur India Share Price Target Set at Rs 525 for 2026
FY27 Earnings Recovery and Revenue Acceleration
The Dabur India share price target of Rs 525 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for a re-rating from CMP Rs 435.45. The Rs 525 price objective represents the base case with FY27 execution as the key variable.
Structural Sector Tailwinds in FMCG Healthcare and Ayurveda
The FMCG Healthcare and Ayurveda sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising corporate investment. Dabur India’s market position among peers in FMCG like Himalaya Drug and Patanjali creates a structural growth runway. Sustained sector outperformance is one of the key conditions for the Rs 630 bull case to materialise.
RBI Rate Cut Cycle and Lower Cost of Capital
India’s RBI rate cut cycle in 2026 is reducing borrowing costs and stimulating end market demand. Lower interest costs improve Dabur India’s EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 525 analyst consensus.
Union Budget 2026-27 Capex Push and Policy Support
Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a favourable policy backdrop for Dabur India’s FMCG Healthcare and Ayurveda operations, improving the probability of achieving the FY27 earnings targets that support the Rs 525 price objective.
FII Flow Normalisation After the 2026 Tariff Shock
As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 40x PE, Dabur India is positioned as a beneficiary of institutional reallocation, providing a tailwind toward the Rs 630 bull case over the medium term.
Dabur India Share Price Targets: Short Term, 12 Month, and Long Term
Short Term Dabur India Share Price Target
Near-term support for Dabur India is anchored close to the 52 week low of Rs 302. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating. Investors can use the 52 week low as an entry reference while awaiting FY27 earnings confirmation.
12-Month Dabur India Share Price Target 2026
The 12-month Dabur India share price target 2026 is Rs 525, implying approximately 20 percent upside from CMP Rs 435.45. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows. Track live on NSE ticker DABUR.
Long Term Dabur India Share Price Target: FY27 to FY28
The long term Dabur India share price target for FY27 to FY28 is Rs 630 in the bull case, requiring full earnings delivery, re-rating among peers in FMCG like Himalaya Drug and Patanjali, and sustained institutional buying over a 2 to 3 year horizon.
Bull Case and Bear Case Scenarios for Dabur India in 2026
Bull Case Dabur India Share Price Target: Rs 630
The bull case Dabur India share price target of Rs 630 materialises when FY27 earnings beat analyst estimates, FMCG Healthcare and Ayurveda tailwinds accelerate, and FII flows return strongly to Indian equities, enabling re-rating toward higher peer multiples. From CMP Rs 435.45, this represents approximately 45 percent potential upside.
Bear Case Dabur India Share Price Target: Rs 350
The bear case Dabur India share price target of Rs 350 materialises if FY27 earnings disappoint or FII outflows depress the broader market, risking a test of the 52 week low support near Rs 302.
| Scenario | Target | Key Conditions |
|---|---|---|
| Bull Case | Rs 630 | FY27 beat, sector re-rating, FII inflows |
| Base Case (Analyst Target) | Rs 525 | In-line FY27 delivery, partial FII recovery |
| Bear Case | Rs 350 | FY27 miss, guidance cut, FII outflows |
Key Risks That Could Derail the Dabur India 2026 Price Objective
Global Macro and US Tariff Headwinds
Prolonged tariff tensions and global demand slowdown remain prominent macro risks to the Dabur India share price target of Rs 525, with FII outflows being the direct transmission mechanism to Indian equity valuations.
FY27 Earnings Miss and Guidance Risk
An FY27 earnings miss or downward guidance revision would compress valuation multiples. This is the most direct company-specific risk to the Rs 525 analyst price objective. Investors must monitor quarterly results and management commentary closely.
Competitive Intensity Among FMCG Healthcare and Ayurveda Peers
Intensifying competition from peers in FMCG like Himalaya Drug and Patanjali could compress Dabur India’s market share and pricing power. This structural risk must be weighed when assessing the defensibility of the earnings trajectory that underpins the Rs 525 analyst target for 2026.
Liquidity Risk and FII Selling Pressure
Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. Investors should size positions carefully and maintain stop losses to protect capital if broad market de-rating continues.
How to Invest in Dabur India
Check the Univest Screener for live data
Before considering any investment based on the Dabur India share price target of Rs 525, review Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, margin trends, and management commentary on FMCG Healthcare and Ayurveda sector demand and competition.
Open a Demat account with a SEBI registered stockbroker to trade Dabur India (NSE: DABUR) with regulatory protection. Study the competitive landscape among peers in FMCG like Himalaya Drug and Patanjali before executing any position.
Plan your entry using the 52 week low of Rs 302 as a key support reference. A confirmed FY27 earnings uptick validates the entry case for the Rs 525 price target. Always set a stop loss below the 52 week low.
Restrict any single stock to 3 to 5 percent of your total equity portfolio, especially in the FMCG Healthcare and Ayurveda space where sectoral cycles can amplify volatility beyond initial expectations.
Always consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.
Download the Univest iOS App or the Univest Android App to track Dabur India’s live share price and receive daily stock recommendations.
Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.
FAQs on Dabur India Share Price Target 2026
What is the Dabur India share price target for 2026?
Ans. The Dabur India share price target 2026 is Rs 525, implying approximately 20 percent upside from CMP Rs 435.45. Bull case is Rs 630, bear case is Rs 350.
What was the Dabur India share price target for 2025?
Ans. The 2025 price objective for Dabur India was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 525, reflecting FY27 growth potential from CMP Rs 435.45.
Is Dabur India a good investment at Rs 435.45?
Ans. At Rs 435.45, Dabur India offers potential upside toward Rs 525 if FY27 earnings recover. Consult a SEBI registered financial advisor before investing based on any price target.
What are the key risks to the Dabur India share price target 2026?
Ans. Key risks to the Dabur India share price target of Rs 525 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in FMCG Healthcare and Ayurveda. Monitoring quarterly results is essential.
What is the 52 week high and low of Dabur India?
Ans. The 52 week high of Dabur India is Rs 714 and the 52 week low is Rs 302. At CMP Rs 435.45, the stock is below its 52 week high and offers upside toward the Rs 525 price objective.
What are the main growth catalysts for Dabur India in 2026?
Ans. Key catalysts include FY27 PAT recovery, FMCG Healthcare and Ayurveda tailwinds, RBI rate cuts in 2026, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.
How does Dabur India compare to its peers?
Ans. Dabur India operates in FMCG Healthcare and Ayurveda alongside peers in FMCG like Himalaya Drug and Patanjali. At CMP Rs 435.45 with MCap Rs 77,017 crore, it is a potential re-rating candidate toward the Dabur India share price target of Rs 525 on FY27 delivery.
What is the Dabur India share price target for 2027?
Ans. The long-term Dabur India share price target for FY27 to FY28 is Rs 630 in the bull case, assuming earnings growth, sector re-rating, and FII inflows. Consult a SEBI registered financial advisor for personalised guidance.
